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Abstract
Background: As a result of high-throughput genotyping methods, millions of human genetic
variants have been reported in recent years. To efficiently identify those with significant biological
functions, a practical strategy is to concentrate on variants located in important sequence regions
such as gene regulatory regions.
Results: Analysis of the most common type of variant, single nucleotide polymorphisms (SNPs),
shows that in gene promoter regions more SNPs occur in close proximity to transcriptional start
sites than in regions further upstream, and a disproportionate number of those SNPs represent
nucleotide transversions. Additionally, the number of SNPs found in the predicted transcription
factor binding sites is higher than in non-binding site sequences.
Conclusion: Current information about transcription factor binding site sequence patterns may
not be exhaustive, and SNPs may be actively involved in influencing gene expression by affecting the
transcription factor binding sites.
Background
Genetic variation has been found to be a ubiquitous phe-
nomenon, and forms the genetic basis for species diver-
sity. Currently, there are sequence variant data
accumulated for humans [1], mouse [2], soybean [3] and
other organisms. With the completion of Human
Genome Project [4], the study of genetic variation has
become one of the keystones in biomedical research, not
only because it affects an individual's anthropometric
characteristics but also because it influences risk of disease
and response to environmental challenges [5]. The infor-
mation derived from the study of variation not only deep-
ens our understanding of human genes and evolution, but
also brings benefits to the identification and treatment of
human genetic diseases.
There are several different types of genetic sequence vari-
ants, including single nucleotide polymorphisms (SNPs),
small deletion and insertion polymorphisms (indels),
micro-satellite markers, and polymorphic insertion ele-
ments such as retrotransposons [6]. Because the most
common variants are SNPs, the term is often abused as a
synonym for genetic sequence variation. However, here
we restrict its usage to the formal SNP definition: a single
base change at a single position.
As a result of high-throughput genotyping methods, mil-
lions of human SNPs have been reported in recent years.
To more efficiently study those with significant biological
functions, a practical method is to concentrate efforts on
SNPs located in genomic regions with important func-
tions. There have been several studies focusing on
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evaluating how SNPs impact phenotype. For example,
Ramensky et al. [7] have applied several rules to predict
biological effects amino acid substitutions made by non-
synonymous coding SNPs. Clifford et al. [8] have
explored non-synonymous coding SNPs effects on protein
function through exploring those introducing amino acid
alterations in protein motif regions.
Another genome region important to gene function are
gene regulatory regions. Through binding of specific tran-
scription factors, gene promoters are directly involved in
gene transcription initiation and regulation. Thus
sequence variation in gene promoters may alter transcrip-
tion factor identification and binding, which in turn can
influence gene expression and effect biological impacts.
For example, it has been found that one allele of the HLA-
G gene (-725G), whose products inhibits maternal anti-
fetal immune response, is highly associated with increas-
ing risk for miscarriage [9]. One possible explanation is
that the SNP falls within the binding site of interferon
response factor-1 (IRF-1), affecting IRF-1 binding and
down-regulating transcription of the HLA-G gene.
Here we analyze the distribution of SNPs in human gene
regulatory regions. Putative transcription factor binding
sites in the gene promoters were computationally derived
and compared to previously identified SNPs. The results
show that SNPs have differential distribution characteris-
tics both in gene regulatory regions and in transcription
factor binding sites when compared to the entire genomic
SNP population.
Results
The build 33 release of the genome sequence contains 545
contig sequences mapped across all of the Homo sapiens
chromosomes. 19,741 gene sequences were extracted
from NCBI RefSeq database, which were linked to contig
sequences by 15,803 LocusLink entries. While most loci
have only one gene, some have two or more forming the
structure of a gene cluster. In addition, sequence version
discrepancies between the databases lead to the removal
of approximately 3000 genes. The loss of these genes does
not create any bias, as the errors in the affected sequence
records were randomly distributed across the databases
with no discernible pattern. Thus the final sequence data
consisted of derived promoter regions for 16,429 genes.
TFD contains 3,749 mammalian transcription factor
binding site sequences, with approximately 2,000 of them
being found at least once in the derived gene promoter
sequences. More than 1,700 binding sites were not found,
presumably because they are either non-human, located
outside the immediate upstream gene regions, or are
binding sites for trans-regulatory elements. The number of
predicted binding sites per promoter follows a normal
distribution.
SNP distribution in gene promoters
Over 35,000 SNPs were found in the gene regulatory
regions. More than 99.8% of them are two state alleles.
The nucleotide substitution rates of promoter SNPs with
two alleles are shown in Table 1. For comparison, substi-
tution rates for all SNPs in the dbSNP database are also
listed. In both sets of SNPs, transition class SNPs account
for approximately two-thirds of the total number. This is
not surprising, as the mismatches made by substitution
within the same chemical group is thermodynamically
more stable [10]. The remaining one-third SNPs are
roughly evenly distributed across the four transversion
types.
For SNPs in promoter regions, G/C substitution is higher
than other nucleotide substitutions in the transversion
type, which corresponds to the higher GC content in gene
promoters. The distributions of SNPs of different types are
plotted in Figure 1, which demonstrates that promoter
SNPs are not evenly distributed in the promoter range of
[-2000, -1], with more SNPs are observed in the region
close to the transcriptional start site. While the numbers of
SNPs of all types are all increased in the region near tran-
scriptional start site, the number of SNPs of transversion
type shows the largest increase.
Transcription factor binding site redundancy
Data redundancy of transcription factor binding site
motifs was evaluated by comparing binding site sequence
similarity, which was divided into three categories: exact
coverage, partial coverage and single nucleotide differ-
ence. The results of these three categories are shown in
Table 2. There are 310 pairs of binding sites with exact
sequence coverage such that the sequences can be repre-
sented using more generalized patterns. There are 1,114
pairs with partial coverage properties that can be regarded
as a subsequence of other binding sites. Finally, 833 pairs
are found with sequences that differ only at a single nucle-
Table 1: Nucleotide substitution rate. Nucleotide substitution 
rates for SNPs in promoter regions (P) and all SNPs 
genomewide (A) show roughly similar rates for transition and 
transversion substitution, with a slight increase in CG 
transversions as would be expected from CG rich regions.
Type Substitution Frequency (P) Frequency (A)
Purine A ↔ G 31.55% 33.10%
Pyrimidine C ↔ T 30.99% 33.10%
Purine ↔ Pyrimidine C ↔ G 12.75% 8.93%
Purine ↔ Pyrimidine A ↔ C 9.43% 8.77%
Purine ↔ Pyrimidine G ↔ T 9.33% 8.82%
Purine ↔ Pyrimidine A ↔ T 5.94% 7.42%BMC Genomics 2005, 6:140 http://www.biomedcentral.com/1471-2164/6/140
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otide position. Potential data redundancy of the binding
site sequences makes it uninformative to study individual
binding sites in the partial coverage and single nucleotide
difference categories, so these motif pairs were merged
into single motifs.
Transcription factor binding sites distribution in gene 
promoters
The distribution of binding sites in the gene promoter
regions is not uniform, as shown in Figure 2. In the range
of -2000 to -400 upstream the frequency is fairly constant.
However the frequency increases in the regions closer to
the transcriptional start site, reaching two to three times
higher in the -100 to -50 range than that in the further
sequence regions. This suggests most transcription factor
binding sites occur within 250 bp of the initiation site.
Beyond the transcriptional start site the frequency of bind-
ing sites decreases dramatically, with the frequency value
dropping below that of the entire upstream sequence.
Changing the expectation value from 0.1 to 0.01 causes
the overall transcription factor binding site frequency to
become smaller. The decrease is uniform across the entire
sequence range of -2000 to 200, as fewer binding site
sequence patterns fulfilling the match criteria are detected.
This uniformity suggests there is no issue of selective
sensitivity.
Transcription factor binding sites in random sequence
datasets simulating promoter sequence in the range of -
2000 to -1 were predicted using an expect value 0.1, and
the results are shown in Figure 3. There is a measurable
Distributions of SNPs in different categories in gene promoter regions Figure 1
Distributions of SNPs in different categories in gene promoter regions. Each symbol represents the average number 
of SNPs found in a 20 bp bin across approximately fourteen thousand promoter sequences with a full length of 2000. This com-
posite statistic shows the SNP density increases in proximity to the transcriptional start site.
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Table 2: Transcription factor binding site sequence similarity. Examples of the three classes of degeneracy in binding site sequence 
motifs. For motif pairs with exact coverage, the less restrictive motifs were used. Motif pairs in the partial coverage and single 
difference categories were merged into a composite motif.
Category Pair Number Binding Site Examples
Sequence Site Name
Exact Coverage 310 YYCCGCCC
CCCCGCCC
EARLY-SEQ1
(Sp1)-TK.1
Partial Coverage 1,114 TGGNNNNNNGCCA
YTGGCANNNTGCCAR
NFI_CS3
TGGCA_RS
Single Difference 833 TKCTGATTGTYTMM
TKCTGATTGGYTMM
E-alpha_Y_box
NF-Y_CS
Distribution of transcription factor binding sites in gene promoter regions Figure 2
Distribution of transcription factor binding sites in gene promoter regions. The x-axis is the position index of gene 
promoter sequence, and the y-axis is the occurrence frequency of the binding sites across all promoters. Only genes with full 
length promoter sequences were included in calculation (approximately 14,000 sequences). A portion of the downstream 
sequence relating to transcriptional start site was also included. The position with index of 0 specifies the transcriptional start 
sites.
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difference in the occurrence of transcription factor bind-
ing sites in the real promoter sequence dataset and the
randomly generated sequence dataset. Three-fold more
binding sites are detected in the random sequences than
in the real promoter sequences, suggesting a non-random
nucleotide distribution in real promoter sequences.
The patterns of transcription factor binding site occur-
rence in the two random sequence datasets are different.
For completely random sequences, the occurrence
appears to be flat across the whole range. However, in the
frequency-based random sequences an increased appear-
ance is observed in the sequence range close to transcrip-
tional start sites similar to the pattern in the real promoter
dataset. As the only difference between these two random
datasets is the nucleotide emission probabilities at each
sequence position, it suggests that transcription factor
binding sites are biased by sequence composition. As GC
content is enriched in the regions close to transcriptional
start site [11], the fact that more transcription factor bind-
ing sites are observed in the promoter region near tran-
scriptional start sites indicates that the binding site
sequences are GC skewed.
SNP distribution in transcription factor binding sites
For 34,858 promoter SNPs mapped to 13,723 promoter
regions, 2,078 (5.9%) of them are located in the predicted
transcription factor binding sites, and 1,969 (5.6%) of
Comparison of transcription factor binding site distributions in random sequence datasets and real promoter sequence dataset Figure 3
Comparison of transcription factor binding site distributions in random sequence datasets and real promoter 
sequence dataset. Each curve represents the occurrence frequency of predicted binding sites in different data sets of compa-
rable size. "Real Random Seq" is a data set of completely random sequences in which the emission probabilities of A, C, G and 
T were equal and uniform across the entire 2 kb. "Adjusted Random Seq" is a data set of random sequences generated with the 
adjusted emission probabilities of A, C, G and T according to that in the corresponding position at the real promoter 
sequence. "Real Seq" is the real promoter sequence dataset. An expectation value of 0.1 was used for detecting transcription 
factor binding sites in these datasets.
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them have alleles introducing new binding sites. The over-
lap of these two SNP sets has 243 members, indicating
that their alleles may have different effects on transcrip-
tion factor binding.
The nucleotide frequency of SNPs falling inside and out-
side transcription factor binding sites is shown in Table 3.
The frequency of SNP distribution in the overall gene pro-
moter region is 0.13%. However, the frequency increases
to 0.20% (p = 2.2 × 10-16) in the predicted transcription
factor binding site regions.
A set of 293 experimentally derived transcription factor
binding sites (associated with 85 genes) drawn from
TRANSFAC were linked to predicted transcription factors
used for this study. Of these, 13 contained SNPs, as shown
in Table 4. The total number of nucleotides organizing the
293 TF binding sites is 5131. With 13 SNPs, the frequency
of SNPs in the TF binding site sequence is 0.25%, a value
not significantly different from the frequency of promoter
SNPs in the putative TF binding sites (p-value = 0.348).
Discussion
Gene promoters for this study were derived using the
human genome contig sequences and the RefSeq gene
sequences, which are synthesis products of NCBI Gen-
Bank [12] records and other information sources. One
concern is whether the gene sequences have reliable tran-
scriptional start sites. The traditional experimental meth-
ods for identifying transcriptional start sites, such as S1
nuclease mapping [13], primer extension [14] and 5'
RACE [15] are technically difficult and not always reliable.
Consequently, the Eukaryotic Promoter Database [16],
which collects the data from literatures, has only several
hundred data entries.
In contrast, the Database of Transcriptional Start Sites [17]
uses the full length cDNA library created by oligo-capping
[18] to capture the longest mRNA transcript, and has accu-
mulated more than 400,000 sequence entries. These
cDNA sequences have been compared with the gene
sequences in the RefSeq database to find the target genes
and used to study the difference of the transcriptional start
sites in the two datasets. According to DBTSS, for 8397 full
length cDNA sequences whose corresponding RefSeq
gene have been identified and compared, more than 85%
of them have transcriptional start site differences equal to
or less than 50 nucleotides. Thus the RefSeq gene
sequences are relatively reliable in defining the transcrip-
tional start sites.
Although more than 85% of RefSeq gene sequences have
almost exact transcriptional start sites, it is possible that
some of the derived upstream sequences may not be real
gene promoters. The impact of false promoters on the
observations is minimal however, as the statistics are
calculated using composite statistics. The use of compos-
ite statistics also reduces potential bias introduced by
highly studied genes, where there might be a greater
number of SNPs simply due to a greater number of
sequenced individuals, and bias due to the greater interest
in the 200 bp immediately upstream of the transcription
start site. The normal distribution of binding sites per pro-
moter also argues against any bias due to frequently stud-
ied genes, because if there were such study bias we would
expect a bimodal distribution with the frequently studied
genes having more SNPs forming one mode, and the less
studied genes with fewer SNPs forming the second.
Transcription factor binding site prediction algorithms
tend to over-predict sites. However, correlation of experi-
mentally determined sites with the predicted sites showed
no significant deviation in the number of SNPs falling
within confirmed or predicted transcription factor bind-
ing sites. The nucleotide frequency of SNPs in experimen-
tal transcription factor binding site sequence is 0.25%,
which is comparable with the 0.20% nucleotide
frequency of promoter SNPs in the putative TF binding
sites, and significantly higher than the 0.13% overall
nucleotide frequency in the promoter sequences used in
this study. Thus we are reasonably certain that the obser-
vations reflect a real phenomenon.
When transcription factor binding sites are mapped on
gene promoter regions, the anchoring transcriptional start
site forms a separating point as shown in Figure 2.
Table 3: Promoter SNPs distribution on predicted transcription factor binding sites. Frequency of SNPs appearing in promoter 
regions and in putative transcription factor binding sites. The frequency of SNPs is significantly higher in putative binding sites than in 
the surrounding sequence (p = 2.2 × 10-16).
Categories SNPs Nucleotides Frequency
Inside a binding site 3,804 1,890,176 0.20%
Outside the binding site 31,054 25,555,824 0.12%
Total 34,858 27,446,000 0.13%BMC Genomics 2005, 6:140 http://www.biomedcentral.com/1471-2164/6/140
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Upstream of the transcriptional start site, occurrence fre-
quency of binding sites goes up, whereas the frequency is
reduced downstream of the start site. It is clear that SNP
distribution in gene promoter sequences is not even. SNPs
occur more often in regions close to transcriptional start
site than further regions, as is shown Figure 1. This con-
forms to other observations that the SNP distribution in
human chromosomes is not uniform [19].
In general, SNP frequency is directly related to the evolu-
tionary pressure on the target genome regions. For exam-
ple, more SNPs are accumulated in repetitive sequence,
introns and pseudogenes, as the evolution pressure in
these regions is relatively low compared to functional
gene sequence regions. Given this hypothesis, it is difficult
to explain why more SNPs are observed in the sequence
region close to transcriptional start site, as the region is
important to the initiation of gene transcription, and
sequence alteration has potentials to influence gene
expression.
One possible explanation is that higher SNP frequency is
related to important functions of the regions close to tran-
scription start sites. The accumulation of SNPs in the
human genome is like a snapshot of human evolutionary
history in which genes, especially those with specific func-
tions, are under continuous natural selection pressure and
alteration by mutation, genetic drift and gene flow. As a
result, the expression pattern of a gene may be changed.
While some genes become totally inactive, others experi-
ence expression level alteration. It is possible that SNPs
occurring in gene promoter regions play an important role
in such scenario, so that the higher frequency of SNPs
close to transcriptional start site is related to subtle altera-
tion of gene expression which results in population
diversity.
Nucleotide changes caused by SNPs can be classified as
transitions and transversions. Generally, transitions are
more conservative, because the substituted nucleotides
belong to the same chemical group, purine or pyrimidine.
In contrast, SNPs resulting in transversions involve nucle-
otide substitution across purine and pyrimidine chemical
groups. The different chemical structures normally limit
the occurrence of SNPs of transversion type, however such
SNPs have increased frequency in regions close to tran-
scriptional start site as shown in Figure 1. Comparison of
nucleotide substitution rates for SNPs in gene promoter
regions versus the entire genome also demonstrates that
transversion SNPs are increased in promoter regions. It is
notable that SNPs with C/G substitution are significantly
increased, suggesting that SNPs with unfavorable struc-
ture substitution are indeed selected for in the gene pro-
moter regions close to transcriptional start site.
One explanation for the increased SNPs of transversion
type may lie in the gene transcription mechanism. During
gene transcription, the DNA double helix needs to be
opened so that one strand can be used as the template for
producing mRNA. In the DNA double helix structure,
there are two hydrogen bonds between A and T base pairs
and three hydrogen bonds between G and C base pairs,
thus opening a G-C base pair requires more energy than
an A-T base pair opening does. GC-rich regions often
require formation of protein-DNA complexes to facilitate
helix opening. Involvement of proteins allows tighter con-
trol mechanisms on gene transcription so that gene
expression can more accurately respond to environmental
conditions. An increased frequency of SNPs with C/G sub-
stitutions may be evolutionarily selected for to maintain
higher GC content and allowing changes of transcription
regulation based on sequence alteration.
Table 4: Promoter SNPs distribution on experimental transcription factor binding sites. Genes which have SNPs in experimentally 
determined transcription factor binding sites. The frequency is not significantly different from the frequency of promoter SNPs in the 
putative TF binding sites (p-value = 0.348).
Gene Accession 
ID
SNP Accession 
ID
SNP 
Position
TF Binding 
Site Start
TF Binding Site 
End
Binding Site Name TRANSFAC Binding 
Site ID
NM_000384 rs9282608 -149 -155 -134 ApoB-site [25] R03692
NM_000384 rs13306199 -82 -86 -61 AF-1-k-apoB [26] R01612
NM_005252 rs4645852 -84 -85 -78 c-fos.5 [27] R00470
NM_002467 rs4645940 -1827 -1834 -1820 c-myc-PUR [28] R04301
NM_002467 rs13250910 -322 -326 -310 NHE [29] R01804
NM_002690 rs2307158 -83 -93 -75 Sp1-human-beta-polymerase [30] R00287
NM_002690 rs2307155 -55 -72 -51 CREB-beta-polymerase [31] R00288
NM_000805 rs9889551 -100 -102 -95 gastrin-negative-element [32] R02031
NM_000176 rs10482604 -708 -713 -691 GRFE [33] R03301
NM_000600 rs13447445 -64 -80 -64 NF-kappaB-IL-6 [34] R01634
NM_000208 rs1864010 -494 -511 -486 Sp1-insulin_receptor [35] R03287
NM_002123 rs2854271 -106 -117 -99 HLA-DQB1-Xbox [36] R03695
NM_001063 rs8177185 -617 -623 -599 transferrin-undefined-site [37] R01453BMC Genomics 2005, 6:140 http://www.biomedcentral.com/1471-2164/6/140
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It is curious that there are more SNPs in binding site
regions than in normal sequence regions. This is contra-
dictory to the hypothesis that transcription factor binding
sites are highly conserved because they are important to
gene transcription regulation. It is possible that the obser-
vations are an artifact and the identified putative tran-
scription factor binding sites are not real binding sites for
human genes. As the binding site sequence patterns used
are in the mammalian category of the TFD database, some
transcription factor binding sites may belong to organ-
isms other than human. However, the false positive bind-
ing sites would be simply normal sequence regions in
gene promoter which should have the lower genomic SNP
frequency, biasing the frequency downward rather than
upward.
A second potential artefact is quality control in the tran-
scription factor binding site data used. While data redun-
dancy may exist as shown in Table 2, it is possible that
some binding site sequence patterns are not exhaustive.
Thus, identified SNPs in the binding sites may have no
influence on the binding site integrity and therefore will
not affect transcription factor binding and gene expres-
sion. This hypothesis cannot be ruled out computation-
ally and will require experimental results to confirm if a
SNP found in a transcription factor binding site can exert
a real effect on gene expression. If not, the sequence pat-
tern of the binding site needs to be expanded. However,
the sequence patterns used for prediction represent con-
sensus sequences drawn from experimental data, and are
probably relatively stable and exhaustive.
A third explanation for increased observation of SNPs in
the binding sites is that SNPs are involved in altering gene
expression during evolution through affecting the binding
site sequences. Effects of SNPs in the binding site is likely
not simple. While some binding sequence changes made
by SNPs may totally interrupt gene expression, others may
only influence the level of expression. Considering that
gene transcription is a complex process involving many
transcription factors, a single position change may not
influence all of them. In evolution, the requirement for
adjusting certain gene expression level to certain environ-
mental factors forms a natural selection on gene regula-
tion, on which SNPs occurring in transcription factor
binding site have direct effect. Therefore, the fact that
more SNPs are in the binding sites may demonstrate
diverse requirements for different gene expression under
different condition.
Conclusion
A biological explanation for increased observation of
SNPs in the binding sites may be that SNPs are involved
in altering gene expression during evolution by affecting
the binding site sequences. The effects of SNPs in the
binding site is likely not simple. While some binding
sequence alterations made by SNPs may totally interrupt
gene expression, others may only influence the level of
expression. Considering that gene transcription is a com-
plex process involving many transcription factors, a single
position change may not influence all of them.
In evolution, the requirement for adjusting certain gene
expression level to certain environmental factors forms a
natural selection on gene regulation, on which SNPs
occurring in transcription factor binding site have direct
effect. Therefore, the fact that more SNPs are in the tran-
scription factor binding sites may demonstrate diverse
requirements for different gene expression under different
condition. Thus, promoter SNPs may be an active factor in
natural selection on gene transcription.
Methods
Data from four different sources (LocusLink, Genome,
TFD, and dbSNP) were used to generate the promoter SNP
data set. At each step, a number of steps to clean and nor-
malize the data were undertaken. Figure 4 shows the gen-
eral steps and data sources used in our investigation.
Gene promoter identification
Gene promoter sequences were calculated using human
genome contig sequences (build 33) from NCBI and gene
location information from LocusLink. For single gene
loci, the gene was mapped onto its target contig using the
scope value, reverse complementing the contig sequence
as necessary. The 2 kb sequence immediately upstream of
the transcriptional start site was then extracted and used as
the promoter sequence. For genes located closer than 2 kb
to the start of contig sequence, the length of the extracted
upstream sequence was limited to the available sequence.
Loci having more than one gene suggest that genes are co-
transcribed, or gene products resulting from alternative
splicing. Therefore, the start site of the first gene in the
locus was used to derive the upstream sequence, which
was used as the promoter sequence for all of the genes in
the locus. The few conflicts from data discrepancies across
different NCBI databases were resolved by forcing agree-
ment on sequence version in the data extraction pipeline.
SNP distribution in gene promoters
Promoter SNPs were mapped using the SNP location
information from dbSNP [6]. Non-unique and loosely
mapped SNPs accounted for only 5.5% for the total
number of SNPs and were excluded. SNPs were then clas-
sified according to the substitution type as either transi-
tions, which includes nucleotide substitution within the
purine (A/G) or pyrimidine (C/T) group, or as transver-
sions, which represents substitution across the groups.
The general distribution pattern of SNPs was then
computed.BMC Genomics 2005, 6:140 http://www.biomedcentral.com/1471-2164/6/140
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Data redundancy of transcription factor binding sites
Transcription factor binding site sequences were acquired
from the Transcription Factor Database (TFD) [20]. The
database contains more than three thousand mammalian
binding site sequence entries encoded using the nomen-
clature of International Union of Pure and Applied Chem-
istry (IUPAC) [21]. Inspection of the sequence data
revealed that some sequences differ at only one or two
nucleotides, and some are subsequences of other
sequences. To evaluate possible data redundancy, the
binding site sequences were mutually compared and the
sequence pairs were grouped into three categories: exact
coverage (a complete match), partial coverage (one is a
subsequence of the other) and single nucleotide differ-
ence (differing at an internal nucleotide). Binding sites in
the partial coverage and single nucleotide difference cate-
gories were merged.
Transcription factor binding site identification and 
distribution in gene promoters
Transcription factor binding sites were predicted using a
suffix tree algorithm [22,23]. The IUPAC codes were fully
expanded and placed into a suffix tree, which allows the
exact promoter sequence string to be searched against the
Flow chart of analysis steps used to generate data set Figure 4
Flow chart of analysis steps used to generate data set. A high-level view of the methods used to generate the data sets 
used in this study. Canonical data sources are shown in bold, and general steps are shown in italics. Parenthetical numbers indi-
cate the number of unique data elements in the data set.BMC Genomics 2005, 6:140 http://www.biomedcentral.com/1471-2164/6/140
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binding site motifs while preserving the degeneracy of the
binding sites. The probability of the binding site motif
appearing by chance was computed using an expectation
value given by the equation  , where k  is the
number of possible nucleotides at position i.
The distribution of binding sites in gene promoters was
examined in order to identify the relation between occur-
rence of binding sites and location in gene promoter
regions. Calculations were performed only upon the full
length (2 K bp) promoters sequence. A 200 bp portion of
the gene subsequence just downstream of the transcrip-
tional start site was also included with the promoter
sequences. Expectation values of 0.1 and 0.01 were used
as the control for binding site significance.
To evaluate the chance appearance of transcription factor
binding sites, we computed their occurrences in two
HMM-generated random datasets that simulate the pro-
moter sequence range of [-2000, -1]. The first dataset was
created by assigning equal an emission probability to all
four nucleotides at each position, while for the second
dataset the emission probability of nucleotide was deter-
mined according to the observed nucleotide probabilities
from the real promoter dataset. Both simulated data sets
contained the same number of sequences as the real pro-
moter set.
SNP distribution in putative binding sites
Integrity of transcription factor binding sites was analyzed
by comparing the SNP distributions within and outside
the putative transcription binding sites. The transcription
factor binding site data set contained both the binding
sites directly identified from the canonical sequence, and
the binding sites "recovered" by substituting previously
identified SNP into the sequence.
SNP distribution in experimentally derived binding sites
Experimentally derived transcription factor binding sites
were retrieved from TRANSFAC database 6.0 [24], the
eukaryotic transcription factors database. To evaluate
whether SNPs occur in the experimentally derived TF
binding sites, we linked the predicted TF binding sites
with the binding sites in TRANSFAC using RefSeq litera-
ture references. The initial linkage was then confirmed
using binding site sequence patterns, site locations and
the order of the binding sites in gene promoter.
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